Status:
UNKNOWN
Double-Blind, Placebo-Controlled Trial of Eefooton in Patients With Chronic Kidney Disease
Lead Sponsor:
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Collaborating Sponsors:
Morris Enterprise Co.,Ltd.
Conditions:
Chronic Kidney Diseases
Renal Insufficiency, Chronic
Eligibility:
All Genders
20-85 years
Phase:
NA
Brief Summary
This phase II study, 24-week, double-blind, study evaluated Eefooton's safety and efficacy for patients with CKD stage 3 to 4 Not on dialysis.
Detailed Description
The purpose of this clinical observation and research is to evaluate the eGFR changes in the renal function of patients with chronic kidney disease combination the Eefooton oral solution and commonly ...
Eligibility Criteria
Inclusion
- Patients with chronic kidney disease who have signed the subject's consent and the glomerular filtration rate (eGFR) is less than 59ml/min/1.73m2
- Both male and female patients aged 20-85 years old are acceptable
- You must be able to come back at a specific time each month during the 6-month trial
Exclusion
- Drug abuse.
- Heart failure (stage 3-4)
- Mental illness (psychotic disorder, epilepsy, depression, panic disorder)
- Patients who have undergone dialysis or are expected to have a kidney transplant in the last three months
- The blood pressure still exceeds 150/90mmHg after using more than three antihypertensive drugs
- Pregnancy or planning to become pregnant or breastfeeding
- Malignant disease
- Acute illness (hepatitis, jaundice, acute myocardial infarction) in the last 3 months
- The patient is engaged in another research study.
- 3 months before entering the study or having used NSAIDs, anti-rejection drugs or performing imaging agent examinations during the study
- You have participated in other research study in the previous month
- You have drug dependence and drinking habits
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05227313
Start Date
March 1 2022
End Date
December 31 2024
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nephrology, Taipei Tzu Chi Hospital, Taipei, Taiwan
Taipei County, Taiwan